Site Search

Share

X

Search Results

NJ Senate Commerce Committee Advances Biomarker Testing Bill

... today Senate Commerce Committee members took a meaningful step toward expanding access.” The power of biomarker testing extends beyond cancer care to the treatment of diseases such as arthritis, other autoimmune conditions and rare diseases. Peggy Lotkowictz dealt with severe discomfort ... I’ll be using this energy to urge lawmakers to gift patients this incredible resource in 2025.” There is consensus across medical and public health leaders that biomarker testing is increasingly important to reducing risk of death, improving quality of life for many cancer patients and ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We stand with our volunteers, working to make cancer a top priority for policymakers in ...

Governor Abbott Signs Legislation that Improves Access to Precision Testing for More Texans

AUSTIN, TX – June 2, 2023 – Gov. Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to ... advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we know it, for everyone. Join the fight by visiting www.fightcancer.org .         1 1 The new law is aimed at improving health outcomes for Texans Governor Abbott Signs Legislation that Improves Access to Precision Testing for More Texans ...

It is Time to Reduce the Burden of Cancer on Buckeyes

... testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state-regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment.  “Furthermore, legislation to address copay ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...

Florida Legislature Passes Bill Taking First Step to Expand Access to Biomarker Testing

... The bill requires coverage for biomarker testing when supported by scientific and medical evidence under Florida Medicaid and state employee health insurance plans. However, it leaves out those covered by state-regulated private health insurance plans on the marketplace, which often include tourism, hospitality and agriculture employees who aren’t offered coverage through ... policymakers to bring this opportunity to the private market. All patients facing cancer and other diseases deserve to get the best possible care.” 0 Bill Stops Short of Requiring Coverage for Private Market Florida Legislature Passes Bill Taking First Step to Expand Access to ...

Maine Lawmakers Should Make a New Year’s Resolution to Prioritize Cancer Related Public Policy

... Year and begin the 2025 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) calls on lawmakers to prioritize public health and focus on a multipronged approach to cancer prevention and cancer treatment: increasing the tax on cigarettes by $2 per pack with a ... “With a new year and new legislative session upon us, Mainers – citizens and lawmakers alike – are thinking about how they can ensure good health for 2025.  Fortunately, we have some of the answers,” said Julia MacDonald, director of government relations for ACS CAN in Maine. ... our state?” she continued. ACS CAN is also renewing efforts to increase access to biomarker testing - an increasingly important part of cancer care. In the case of a cancer diagnosis, biomarker testing allows doctors to precisely target a specific cancer so some patients may not have to ...

Colorado Cancer Advocates Call on State Lawmakers to Continue Progress in Fight Against Cancer

... lawmakers to help promote cancer prevention, early detection of cancer, and expanding access to new methods of innovative, quality, affordable health care. ACS CAN looks forward to working with Colorado’s leaders in making progress in the fight against cancer in 2025.”  ACS CAN Colorado ... cancer screening and treatment program for low-income uninsured and underinsured women administered by the Colorado Department of Public Health & Environment through the Women’s Wellness Connection. Funding for FY 2025-2026 is projected to be $3 million. These funds are derived ...

Cancer Advocates Urge Colorado Legislators to Take Critical Step to Connect Patients with Most Effective Treatment Options

... They urged lawmakers to pass SB 124 , which if enacted would ensure   biomarker testing  is covered by more insurance plans, including Health First Colorado, when supported by medical and scientific evidence.    “Every year on Cancer Action Day, people who have been touched ... Coloradans are missing out on biomarker testing. Communities of color, individuals with limited income, rural residents and patients receiving care in non-academic medical centers are less likely to receive guideline-indicated biomarker testing. Senate Bill 124 -- co-sponsored by Senator Janice Rich, Senator Dafna Michaelson Jenet and Representative Anthony Hartsook -- would help address this health injustice," said R.J. Ours, government relations director for ACS CAN Colorado.    To date, 15 states across the country have passed ...

Cancer Advocates Commend Colorado Lawmakers for Positive First Step in Opening Door to Precision Medicine

... with the right treatment at the right time through biomarker testing .  The bill would ensure more patients with private insurance will have health insurance coverage for the biomarker testing they need. SB24-124 will affect medical health coverage plans for over one million Coloradans or roughly 33% of those with private health insurance coverage. Unfortunately, the bill does ... improve access to biomarker testing for Medicaid enrollees, which accounts for more than 1.6 Coloradans, according to the Department of Health Care Policy and Financing.  “Biomarker testing can be game changing for many cancer patients,” said R.J. Ours, ACS CAN Colorado government ...

Oncologists Call for Improvements in Access to Biomarker Testing as Assembly Insurance Committee Signals Unanimous Support

... to improve New Yorkers’ access to precision medicine through biomarker testing. Biomarker testing has become a game-changing part of cancer care given its role in opening the door to targeted treatments that can lead to improved survivorship and quality of life. Despite the proven ... York have access to this testing.” “Timely access to guideline-indicated comprehensive biomarker testing can help achieve the triple aim of health care, including better health outcomes, improved quality of life, and, often reduced costs,” said Dr. Allyson Ocean, MD, Attending Physician specializing in ...

Florida needs to increase access to game-changing cancer tests

... testing to precisely identify the mutations unique to a patient’s cancer. Biomarker testing has revolutionized the entire approach to oncology care. We have seen tremendous gains in the understanding and adoption of biomarker testing over the last five years. The results from such testing ... At FCS, we are acutely aware of the long-term cost savings associated with biomarker testing that reduces the financial burden on the health care system. The ability to tailor therapies to specific cancer traits may lead to improved clinical outcomes and cost reduction. The goal of a ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy